← Open Payments lookup

KENNETH ZEMANEK: Open Payments

NPI 1558316174 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,068 in 19 payments from 11 companies in 2025. Trend: 2023 $1,557 · 2024 $1,926 · 2025 $2,068

Food & beverage: $2,041Education: $27
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$612
E.R. Squibb & Sons, L.L.C.3$268
Vanda Pharmaceuticals Inc.2$249
ABBVIE INC.2$224
Alkermes, Inc.1$129
Teva Pharmaceuticals USA, Inc.1$125
Axsome Therapeutics, Inc.1$125
Janssen Pharmaceuticals, Inc1$113
Neurocrine BioSciences, Inc.1$99
Otsuka America Pharmaceutical, Inc.1$99

Products named: CAPLYTA, COBENFY, FANAPT, VRAYLAR, LYBALVI, UZEDY, Auvelity, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.